<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>From a population of patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> one hundred were selected and divided into two groups, with comparable neurological deficit and risk factors </plain></SENT>
<SENT sid="1" pm="."><plain>To one group of patients <z:chebi fb="3" ids="17754">glycerol</z:chebi> was administered, the other group served as a control </plain></SENT>
<SENT sid="2" pm="."><plain>Neurological deficit was scored on the day of admission and in the next 4 weeks </plain></SENT>
<SENT sid="3" pm="."><plain>There was no noticeable beneficial effect of <z:chebi fb="3" ids="17754">glycerol</z:chebi> administration in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>